Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 nov. 2024 21h02 HE | Source: Robbins LLP

EVLV STOCK NEWS: Robbins LLP Encourages Evolv Technologies Holdings, Inc. Stockholders with Significant Losses to Seek Counsel for the EVLV Class Action

Robbins LLP is Investigating Allegations that Evolv Technologies Holdings, Inc. (EVLV) Misled Investors Regarding Revenue Recognition
05 nov. 2024 15h27 HE | Source: Robbins LLP

EVLV Stockholder Alert: Robbins LLP Reminds Investors of the Evolv Technologies Holdings, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Evolv Technologies Holdings, Inc. (EVLV) Misled Investors Regarding Revenue Recognition
09 mai 2024 15h17 HE | Source: Robbins LLP

Stockholder Alert: Robbins LLP Reminds EVLV Stockholders of Upcoming May 24, 2024 Lead Plaintiff Deadline in the Evolv Technologies Holdings, Inc. Class Action

Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
15 avr. 2024 16h51 HE | Source: Robbins LLP

EVLV Stockholders Should Contact Robbins LLP for Information about the Evolv Technologies Holdings, Inc. Class Action

Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
05 avr. 2024 13h27 HE | Source: Robbins LLP

EVLV Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Evolv Technologies Holdings, Inc. Class Action

Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products
26 mars 2024 15h56 HE | Source: Robbins LLP

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Evolv Technologies Holdings, Inc. f/k/a Newhold Investment Corp.

Robbins LLP is Investigating the Allegations that Evolv Technologies Holdings, Inc. (EVLV) Overstated the Efficacy of its Products